Shanghai Shyndec Pharmaceutical (600420.SH) has issued a forecast, estimating that annual net profit will be between 1.054 billion yuan and 1.184 billion yuan, an increase of 52.31% to 71.1% year-on-year.

Shanghai Shyndec Pharmaceutical (600420.SH) disclosed its performance forecast for the year 2024, with the company expecting to achieve a net profit attributable to shareholders of listed companies of 1.054 billion to 1.184 billion yuan, an increase of 52.31% to 71.10% year-on-year. Net profit attributable to shareholders of listed companies, excluding non-recurring gains and losses, is expected to be 1.012 billion to 1.142 billion yuan, an increase of 48.17% to 67.20% year-on-year.